One Horizon Group, Inc.
$3 M
Secondary/Follow-On
Sole Book-Runner
EyeGate Pharmaceuticals, Inc.
$10 M
Secondary/Follow-On
Joint Book-Runner
Cryoport, Inc.
$6.5 M
Secondary/Follow-On
Sole Book-Runner
CytRx Corporation
$28.8 M
Secondary/Follow-On
Co-Manager
NephroGenex, Inc.
$7.5 M
Secondary/Follow-On
Sole Book-Runner
GenePeeks, Inc.
$3 M
Debt Capital
Ritter Pharmaceuticals, Inc.
$20 M
IPO
Sole Book-Runner
Caladrius Biosciences, Inc. (fka NeoStem)
$28.8 M
Secondary/Follow-On
Sole Book-Runner
Manhattan Bridge Capital, Inc.
$4.5 M
Secondary/Follow-On
Sole Book-Runner
Jaguar Animal Health, Inc.
IPO
Sole Book-Runner
BiondVax Pharmaceuticals Ltd.
$9.6 M
IPO
Sole Book-Runner
Cyalume Technologies Holdings, Inc.
$25 M